BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10636592)

  • 1. Bone metabolism and circulating IGF-I and IGFBPs in dexamethasone-treated preterm infants.
    Ward WE; Atkinson SA; Donovan SM; Paes B
    Early Hum Dev; 1999 Dec; 56(2-3):127-41. PubMed ID: 10636592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone-induced abnormalities in growth and bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-I.
    Ward WE; Donovan SM; Atkinson SA
    Pediatr Res; 1998 Aug; 44(2):215-21. PubMed ID: 9702917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa.
    Hotta M; Fukuda I; Sato K; Hizuka N; Shibasaki T; Takano K
    J Clin Endocrinol Metab; 2000 Jan; 85(1):200-6. PubMed ID: 10634387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.
    Kim JG; Shin CS; Choi YM; Moon SY; Kim SY; Lee JY
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of type I and type III collagen turnover, insulin-like growth factors, and their binding proteins in cord plasma of small premature infants: relationships with fetal growth, gestational age, preeclampsia, and antenatal glucocorticoid treatment.
    Kajantie E; Hytinantti T; Koistinen R; Risteli J; Rutanen EM; Seppälä M; Andersson S
    Pediatr Res; 2001 Apr; 49(4):481-9. PubMed ID: 11264430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone.
    Weiler HA; Paes B; Shah JK; Atkinson SA
    Early Hum Dev; 1997 Feb; 47(3):271-86. PubMed ID: 9088794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.
    Zhou X; Loke KY; Pillai CC; How HK; Yap HK; Lee KO
    Eur J Endocrinol; 2001 Mar; 144(3):237-43. PubMed ID: 11248742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of insulin-like growth factor (IGF)-I and -II and IGF binding proteins (IGFBPs) in fetal stromal-vascular (S-V) cell cultures obtained before and after the onset of adipogenesis in vivo.
    Hausman GJ; Richardson RL; Simmen FA
    Growth Dev Aging; 2002; 66(1):11-26. PubMed ID: 12212627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth restriction in dexamethasone-treated preterm infants may be mediated by reduced IGF-I and IGFBP-3 plasma concentrations.
    Bloomfield FH; Knight DB; Breier BH; Harding JE
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):235-42. PubMed ID: 11207639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of insulin-like growth factor I (IGF-I) and IGF-binding protein measurements to monitor feeding of premature infants.
    Smith WJ; Underwood LE; Keyes L; Clemmons DR
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3982-8. PubMed ID: 9398700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between serum insulinlike growth factor-1, insulinlike growth factor binding protein-2, and insulinlike growth factor binding protein-3 and nutritional intake in premature infants with bronchopulmonary dysplasia.
    Price WA; Lee E; Maynor A; Stiles AD; Clemmons DR
    J Pediatr Gastroenterol Nutr; 2001 May; 32(5):542-9. PubMed ID: 11429514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dexamethasone treatment on serum GH, IGF-I, and the binding proteins IGFBP-1 and -3 in ventilated very preterm infants.
    Huysman MW; Hokken-Koelega AC; Hop WC; Sauer PJ
    Pediatr Res; 2003 Jul; 54(1):37-43. PubMed ID: 12646720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered bone metabolism in children infected with human immunodeficiency virus.
    Zamboni G; Antoniazzi F; Bertoldo F; Lauriola S; Antozzi L; Tatò L
    Acta Paediatr; 2003; 92(1):12-6. PubMed ID: 12650292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone/insulin-like growth factor-1 axis, calciotropic hormones and bone mineral density in young patients with chronic viral hepatitis.
    Marek B; Kajdaniuk D; Niedziołka D; Borgiel-Marek H; Nowak M; Siemińska L; Ostrowska Z; Głogowska-Szeląg J; Piecha T; Otremba Ł; Holona K; Kazimierczak A; Wierzbicka-Chmiel J; Kos-Kudła B
    Endokrynol Pol; 2015; 66(1):22-9. PubMed ID: 25754278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone.
    Ahmed SF; Tucker P; Mushtaq T; Wallace AM; Williams DM; Hughes IA
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):185-91. PubMed ID: 12153596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasogastric feeding enhances nutritional status in paediatric liver disease but does not alter circulating levels of IGF-I and IGF binding proteins.
    Holt RI; Miell JP; Jones JS; Mieli-Vergani G; Baker AJ
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):217-24. PubMed ID: 10671950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.